AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Evoke PharmaAkornBellicum PharmaceuticalsJaguar HealthRegeneRx Biopharmaceuticals
SymbolNASDAQ:EVOKNASDAQ:AKRXNASDAQ:BLCMNASDAQ:JAGXOTCMKTS:RGRX
Price Information
Current Price$2.54$0.09$8.78$0.44$0.31
52 Week RangeHoldHoldBuyBuyN/A
Beat the Market™ Rank
Overall Score0.71.61.31.70.6
Analysis Score0.03.03.53.50.0
Community Score3.02.72.84.42.8
Dividend Score0.00.00.00.00.0
Ownership Score0.01.00.00.00.0
Earnings & Valuation Score0.61.30.00.60.0
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyN/A
Consensus Price TargetN/A$3.00$17.50$4.00N/A
% Upside from Price TargetN/A3,233.33% upside99.32% upside803.75% upsideN/A
Trade Information
Market Cap$57.30 million$11.98 million$42.42 million$25.58 million$42.03 million
Beta2.030.952.180.80.81
Average Volume295,1279,601,876147,4891,303,18279,781
Sales & Book Value
Annual RevenueN/A$682.43 million$7.14 million$5.78 million$80,000.00
Price / SalesN/A0.026.214.50508.75
CashflowN/A$0.47 per shareN/AN/AN/A
Price / CashN/A0.19N/AN/AN/A
Book Value$0.18 per share$1.86 per share($5.25) per share$0.16 per share($0.02) per share
Price / BookN/A0.05-1.672.77-15.25
Profitability
Net Income$-7,130,000.00$-226,770,000.00$-112,480,000.00$-38,540,000.00$-1,400,000.00
EPS($0.32)($0.34)($19.91)($6.89)N/A
Trailing P/E RatioN/AN/AN/AN/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-55.64%-1,574.65%-755.26%-1,910.16%
Return on Equity (ROE)-147.70%8.53%-664.19%-538.90%N/A
Return on Assets (ROA)-106.96%1.31%-46.80%-88.17%-161.30%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.09%28.20%0.08%N/A
Current Ratio2.64%0.50%1.60%0.42%2.33%
Quick Ratio2.64%0.32%1.60%0.25%2.33%
Ownership Information
Institutional Ownership Percentage6.08%64.03%30.12%0.46%0.19%
Insider Ownership Percentage10.27%3.90%2.64%11.26%11.60%
Miscellaneous
Employees62,227173403
Shares Outstanding24.70 million133.15 million5.05 million58.81 million133.44 million
Next Earnings Date8/13/2020 (Estimated)N/A8/3/2020 (Estimated)8/12/2020 (Estimated)6/10/2020 (Estimated)
OptionableNot OptionableOptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.